Plus-maze retest profile in mice: Importance of initial stages of trial 1 and response to post-trial cholinergic receptor blockade

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 1, 1996, Pages 41-50

  Rodgers, R J ^a   Johnson, N J T ^a   Cole, J C ^a   Dewar, C V ^a   Kidd, G R ^a   Kimpson, P H ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

elevated plus maze; ethological analysis; fear sensitization; learning and memory; mice; retest; scopolamine

Indexed keywords

CHOLINERGIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; AVERSION; BEHAVIOR; CONFERENCE PAPER; CONTROLLED STUDY; ETHOLOGY; EXPLORATORY BEHAVIOR; FEAR; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIZATION;

EID: 0029883151     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02156-6     Document Type: Conference Paper

References (41)

1. Almeida, S. S.; Garcia, R. A.; deOliveira, L. M. Effects of early protein malnutrition and repeated testing upon locomotor and exploratory behaviors in the elevated plus-maze. Physiol. Behav. 54:749-752; 1993.
2. Bartus, R. T.; Dean, R. L.; Pontecorvo, M. J.; Flicker, C. The cholinergic hypothesis: A historical overview, current perspective and future directions. In: Olton, D. S.; Gamzu, E.; Corkin, S., eds. Memory Dysfunctions: An Integration of Animal and Human Research from Preclinical and Clinical Perspectives. New York: NY Acad. Sci. 1985:408-417.
3. Cruz, A. P. M.; Frei, F.; Graeff, F. G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:171-176; 1994.
4. Dawson, G. R.; Crawford, S. P.; Stanhope, K. J.; Iversen, S. D.; Tricklebank, M. D. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology 113: 570-572; 1994.
5. Derrien, M.; McCort-Tranchpain, I.; Ducos, B.; Roques B. P.; Durieux, C. Heterogeneity of CCK-B receptors involved in animal models of anxiety. Pharmacol. Biochem. Behav. 49:133-141; 1994.
6. Falter, U.; Gower, A.; Gobert, J. Anxiogenic effects of scopolamine observed in rats in the elevated plus-maze. In: File, S. E.; Briley, M., eds. New Concepts in Anxiety. London: Macmillan; 1992:332-337.
7. File, S. E. One-trial tolerance to the anxiolytic actions of chlordiazepoxide in the plus-maze. Psychopharmacology 100:281-282; 1990.
8. File, S. E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 58:199-202; 1993.
9. File, S. E.; Mabbutt, P. S.; Hitchcott, P. K. Characterisation of the phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology 102:98-101; 1990.
10. File, S. E.; Zangrossi, H. 'One-trial tolerance' to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology 110:240-244; 1993.
11. File, S. E.; Zangrossi, H.; Sanders, F. L.; Mabbutt, P. S. Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacology 113:543-546; 1994.
12. File, S. E.; Zangrossi, H.; Viana, M.; Graeff, F. G. Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology 111:491-494; 1993.
13. Flood, J. F.; Cherkin, A. Scopolamine effects on memory retention in mice: A model of dementia? Behav. Neural Biol. 45:169-184; 1986.
14. Glick, S. D.; Zimmerberg, B. Comparative learning impairment and amnesia by scopolamine, phencyclidine and ketamine. Psychon. Sci. 25:165-166; 1971.
15. Gold, P. E.; Zornetzer, S. F. The mnemon and its juices: Neuromodulation of memory processes. Behav. Neural Biol. 38:151-189; 1988.
16. Griebel, G.; Moreau, J.-L.; Jenck, F.; Martin, J. R.; Misslin, R. Some critical determinants of the behaviour of rats in the elevated plus-maze. Behav. Proc. 29:37-48; 1993.
17. Handley, S. L.; Spooner, H. A.; McCreary, A. C.; McBlane, J. W. Factor analysis of behaviour in the elevated X-maze. J. Psychopharmacol. 9(Suppl.) A32:127; 1995.
18. Itoh, J.; Nabeshima, T.; Kameyama, T. Utility of an elevated plus-maze for the evaluation of memory in mice: Effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 101:27-33; 1990.
19. Itoh, J.; Nabeshima, T.; Kameyama, T. Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur. J. Pharmacol. 194:71-76; 1991.
20. Kameyama, T.; Nabeshima, T.; Noda, Y. Cholinergic modulation of memory for step-down type passive avoidance task in mice. Res. Commun. Psychol. Psychiat. Behav. 11:193-205; 1986.
21. Lee, C.; Rodgers, R. J. Antinociceptive effects of the elevated plus-maze: Influence of opiate receptor manipulations. Psychopharmacology 102:507-513; 1990.
22. Lister, R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185; 1987.
23. Lister, R. G. Ethologically based animal models of anxiety disorders. Pharmac. Ther. 46:321-340; 1990.
24. McGaugh, J. L. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Ann. Rev. Neurosci. 12:255-287; 1989.
25. Miyazaki, S.; Imaizumi, M.; Machida, H. The effects of anxiolytics and anxiogenics on evaluation of learning and memory in an elevated plus-maze test in mice. Meth. Find. Exp. Clin. Pharmacol. 17:121-127; 1995.
26. Okaichi, H.; Oshima, Y.; Jarrard, L. E. Scopolamine impairs both working and reference memory in rats: A replication and extension. Pharmacol. Biochem. Behav. 34:599-602; 1989.
27. Pazzagli, A.; Pepeu, G. Amnesic properties of scopolamine and brain acetylcholine in the rat. Int. J. Neuropharmac. 4:291-299; 1964.
28. Pellow, S.; Chopin, P.; File, S. E.; Briley, M. Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167; 1985.
29. Quartermain, D.; Leo, P. Strength of scopolamine induced amnesia as a function of time between training and testing. Behav. Neural Biol. 50:300-310; 1988.
30. Rodgers, R. J.; Cole, J. C. The elevated plus-maze: Pharmacology, methodology and ethology. In: Cooper, S. J.; Hendrie, C. A., eds. Ethology and Psychopharmacology. Chichester: Wiley; 1994:8-44.
31. Rodgers, R. J.; Cole, J. C. Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety. Behav. Pharmacol. 6:283-289; 1995.
32. Rodgers, R. J.; Cole, J. C.; Cobain, M. R.; Daly, P.; Doran, P.; Eells, J. R.; Wallis, P. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: Profile comparisons with 8-OH-DPAT; CGS 12066B, TFMPP and mCPP. Behav. Pharmacol. 3:621-634; 1992.
33. Rodgers, R. J.; Johnson, N. J. T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52:297-303; 1995.
34. Rodgers, R. J.; Lee, C.; Shepherd, J. K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology 106:102-110; 1992.
35. Rodgers, R. J.; Shepherd, J. K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology 113:237-242; 1993.
36. Rush, D. R. Scopolamine amnesia of passive avoidance: A deficit of information acquisition. Behav. Neural Biol. 50:255-274; 1988.
37. Sharma, A. C.; Kulkarni, S. K. Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 16:117-125; 1992.
38. Shepherd, J. K. Preliminary evaluation of an elevated 'zero-maze' as an animal model of anxiety in laboratory rats. J. Psychopharmacol. 6:A56; 1992.
39. Shepherd, J. K.; Grewal, S. S.; Fletcher, A.; Bill, D. J.; Dourish, C. T. Behavioural and pharmacological characterisation of the 'elevated zero-maze' as an animal model of anxiety. Psychopharmacology 116:56-64; 1994.
40. Toumane, A.; Durkin, T. P. Time gradient for posttest vulnerability to scopolamine-induced amnesia following the initial acquisition session of a spatial reference memory task in mice. Behav. Neural Biol. 60:139-151; 1993.
41. Treit, D.; Menard, J.; Royan, C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:365-370; 1993.